Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease
Gespeichert in:
Veröffentlicht in: | Journal of cardiovascular risk 1997-04, Vol.4 (2), p.91-99 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 99 |
---|---|
container_issue | 2 |
container_start_page | 91 |
container_title | Journal of cardiovascular risk |
container_volume | 4 |
creator | Panahloo, A Yudkin, J S |
description | |
doi_str_mv | 10.1097/00043798-199704000-00005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79297664</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79297664</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1570-bc0d98322e8496832b7c076c185d11be33d58167512d93f7d3aae97836d86cf63</originalsourceid><addsrcrecordid>eNo9kMlOwzAQhn0AlVJ4BCSfuAXGceLliMoqVeICVyzHdoRRluJJkPr2pDT0MJrtn0UfIZTBDQMtbwGg4FKrjGktoZjSbDIoT8iS8RIykUt5Rs4RvwBYUUq5IAvNoSg0LMnHfWxjF_EzeFrHKsWub3YYkcaO-mirMASkbWiaOIxIbedpHKZmu22is0PsO1r3aVZGR38surGx-woGi-GCnNa2wXA5-xV5f3x4Wz9nm9enl_XdJnOslJBVDrxWPM-DKrSYgko6kMIxVXrGqsC5LxUTsmS517yWnlsbtFRceCVcLfiKXB_2blP_PQYcTBvRTW_bLvQjGqlzLYUoJqE6CF3qEVOozTbF1qadYWD2OM0_TnPEaf5wTqNX842xaoM_Ds4s-S8CnnLX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79297664</pqid></control><display><type>article</type><title>Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease</title><source>MEDLINE</source><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><source>Sage Journals</source><source>Journals@Ovid Complete</source><creator>Panahloo, A ; Yudkin, J S</creator><creatorcontrib>Panahloo, A ; Yudkin, J S</creatorcontrib><identifier>ISSN: 1350-6277</identifier><identifier>DOI: 10.1097/00043798-199704000-00005</identifier><identifier>PMID: 9304490</identifier><language>eng</language><publisher>England</publisher><subject>Arteriosclerosis - genetics ; Arteriosclerosis - physiopathology ; Diabetic Angiopathies - physiopathology ; Fibrinolysis - genetics ; Fibrinolysis - physiology ; Genotype ; Glucose - metabolism ; Humans ; Hypolipidemic Agents - therapeutic use ; Insulin Resistance - physiology ; Obesity - complications ; Plasminogen Activator Inhibitor 1 - genetics ; Plasminogen Activator Inhibitor 1 - physiology ; Risk Factors ; Thrombosis - genetics ; Thrombosis - physiopathology ; Tissue Plasminogen Activator - therapeutic use ; Triglycerides - metabolism ; Vascular Diseases - physiopathology</subject><ispartof>Journal of cardiovascular risk, 1997-04, Vol.4 (2), p.91-99</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1570-bc0d98322e8496832b7c076c185d11be33d58167512d93f7d3aae97836d86cf63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9304490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Panahloo, A</creatorcontrib><creatorcontrib>Yudkin, J S</creatorcontrib><title>Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease</title><title>Journal of cardiovascular risk</title><addtitle>J Cardiovasc Risk</addtitle><subject>Arteriosclerosis - genetics</subject><subject>Arteriosclerosis - physiopathology</subject><subject>Diabetic Angiopathies - physiopathology</subject><subject>Fibrinolysis - genetics</subject><subject>Fibrinolysis - physiology</subject><subject>Genotype</subject><subject>Glucose - metabolism</subject><subject>Humans</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Insulin Resistance - physiology</subject><subject>Obesity - complications</subject><subject>Plasminogen Activator Inhibitor 1 - genetics</subject><subject>Plasminogen Activator Inhibitor 1 - physiology</subject><subject>Risk Factors</subject><subject>Thrombosis - genetics</subject><subject>Thrombosis - physiopathology</subject><subject>Tissue Plasminogen Activator - therapeutic use</subject><subject>Triglycerides - metabolism</subject><subject>Vascular Diseases - physiopathology</subject><issn>1350-6277</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMlOwzAQhn0AlVJ4BCSfuAXGceLliMoqVeICVyzHdoRRluJJkPr2pDT0MJrtn0UfIZTBDQMtbwGg4FKrjGktoZjSbDIoT8iS8RIykUt5Rs4RvwBYUUq5IAvNoSg0LMnHfWxjF_EzeFrHKsWub3YYkcaO-mirMASkbWiaOIxIbedpHKZmu22is0PsO1r3aVZGR38surGx-woGi-GCnNa2wXA5-xV5f3x4Wz9nm9enl_XdJnOslJBVDrxWPM-DKrSYgko6kMIxVXrGqsC5LxUTsmS517yWnlsbtFRceCVcLfiKXB_2blP_PQYcTBvRTW_bLvQjGqlzLYUoJqE6CF3qEVOozTbF1qadYWD2OM0_TnPEaf5wTqNX842xaoM_Ds4s-S8CnnLX</recordid><startdate>199704</startdate><enddate>199704</enddate><creator>Panahloo, A</creator><creator>Yudkin, J S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199704</creationdate><title>Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease</title><author>Panahloo, A ; Yudkin, J S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1570-bc0d98322e8496832b7c076c185d11be33d58167512d93f7d3aae97836d86cf63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Arteriosclerosis - genetics</topic><topic>Arteriosclerosis - physiopathology</topic><topic>Diabetic Angiopathies - physiopathology</topic><topic>Fibrinolysis - genetics</topic><topic>Fibrinolysis - physiology</topic><topic>Genotype</topic><topic>Glucose - metabolism</topic><topic>Humans</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Insulin Resistance - physiology</topic><topic>Obesity - complications</topic><topic>Plasminogen Activator Inhibitor 1 - genetics</topic><topic>Plasminogen Activator Inhibitor 1 - physiology</topic><topic>Risk Factors</topic><topic>Thrombosis - genetics</topic><topic>Thrombosis - physiopathology</topic><topic>Tissue Plasminogen Activator - therapeutic use</topic><topic>Triglycerides - metabolism</topic><topic>Vascular Diseases - physiopathology</topic><toplevel>online_resources</toplevel><creatorcontrib>Panahloo, A</creatorcontrib><creatorcontrib>Yudkin, J S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular risk</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Panahloo, A</au><au>Yudkin, J S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease</atitle><jtitle>Journal of cardiovascular risk</jtitle><addtitle>J Cardiovasc Risk</addtitle><date>1997-04</date><risdate>1997</risdate><volume>4</volume><issue>2</issue><spage>91</spage><epage>99</epage><pages>91-99</pages><issn>1350-6277</issn><cop>England</cop><pmid>9304490</pmid><doi>10.1097/00043798-199704000-00005</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1350-6277 |
ispartof | Journal of cardiovascular risk, 1997-04, Vol.4 (2), p.91-99 |
issn | 1350-6277 |
language | eng |
recordid | cdi_proquest_miscellaneous_79297664 |
source | MEDLINE; Oxford Journals Online; Alma/SFX Local Collection; Sage Journals; Journals@Ovid Complete |
subjects | Arteriosclerosis - genetics Arteriosclerosis - physiopathology Diabetic Angiopathies - physiopathology Fibrinolysis - genetics Fibrinolysis - physiology Genotype Glucose - metabolism Humans Hypolipidemic Agents - therapeutic use Insulin Resistance - physiology Obesity - complications Plasminogen Activator Inhibitor 1 - genetics Plasminogen Activator Inhibitor 1 - physiology Risk Factors Thrombosis - genetics Thrombosis - physiopathology Tissue Plasminogen Activator - therapeutic use Triglycerides - metabolism Vascular Diseases - physiopathology |
title | Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A59%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diminished%20fibrinolysis%20in%20diabetes%20mellitus%20and%20its%20implication%20for%20diabetic%20vascular%20disease&rft.jtitle=Journal%20of%20cardiovascular%20risk&rft.au=Panahloo,%20A&rft.date=1997-04&rft.volume=4&rft.issue=2&rft.spage=91&rft.epage=99&rft.pages=91-99&rft.issn=1350-6277&rft_id=info:doi/10.1097/00043798-199704000-00005&rft_dat=%3Cproquest_cross%3E79297664%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79297664&rft_id=info:pmid/9304490&rfr_iscdi=true |